As of Apr 18
| +0.00035 / +43.75%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +347,726.09% increase from the last price of 0.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.